Series D Completed
Allay Therapeutics Series D
A$57.5m raised
Announced 5 Jun 2025
Investors
Led by
- Lightstone Ventures · Co-lead
- ClavystBio · Co-lead
- WTT investment · Co-lead
With
- NEA · Existing investor
- Arboretum Ventures · Existing investor
- Vertex Growth · Existing investor
- Vertex Holdings · Existing investor
- Brandon Capital Partners · Existing investor
- IPD Capital
- EDBI
- SGInnovate
- Maruishi Pharmaceutical
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- Allay Therapeutics
- Stage
- Series D
- Amount raised
- A$57.5m
- Company based in
- United States
Similar rounds
- Synchron Series D Nov 2025 · led by Double Point Ventures
- PolyActiva Series C May 2025 · A$40m
- Halter Series D Jun 2025 · A$160m · led by Bond
- Brainomix Series C Mar 2025 · A$27.9m · led by Parkwalk Advisors
- PsiQuantum Series E Sep 2025 · led by BlackRock
Sources
- 9 Jun 2025 Allay Therapeutics announces $57.5M Series D financing and venture debt line brandoncapital.vc
- 10 Jun 2025 Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line brandonbiocatalyst.com